Cartesian Therapeutics Inc (RNAC)
24.12
+1.09
(+4.73%)
USD |
NASDAQ |
Jun 25, 16:00
24.12
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics Cash and Short Term Investments (Quarterly): 103.42M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 103.42M |
| December 31, 2023 | 76.91M |
| September 30, 2023 | 79.60M |
| June 30, 2023 | 112.03M |
| March 31, 2023 | 125.92M |
| December 31, 2022 | 134.60M |
| September 30, 2022 | 146.44M |
| June 30, 2022 | 142.06M |
| March 31, 2022 | 117.43M |
| December 31, 2021 | 128.06M |
| September 30, 2021 | 138.66M |
| June 30, 2021 | 150.14M |
| March 31, 2021 | 147.81M |
| December 31, 2020 | 138.68M |
| September 30, 2020 | 146.26M |
| June 30, 2020 | 59.73M |
| March 31, 2020 | 72.61M |
| Date | Value |
|---|---|
| December 31, 2019 | 89.89M |
| September 30, 2019 | 34.23M |
| June 30, 2019 | 41.68M |
| March 31, 2019 | 48.42M |
| December 31, 2018 | 37.40M |
| September 30, 2018 | 50.48M |
| June 30, 2018 | 66.23M |
| March 31, 2018 | 83.14M |
| December 31, 2017 | 96.64M |
| September 30, 2017 | 104.39M |
| June 30, 2017 | 112.66M |
| March 31, 2017 | 68.52M |
| December 31, 2016 | 84.14M |
| September 30, 2016 | 79.28M |
| June 30, 2016 | 84.55M |
| March 31, 2016 | 25.98M |
| December 31, 2015 | 36.46M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
34.23M
Minimum
Sep 2019
150.14M
Maximum
Jun 2021
109.31M
Average
121.68M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Marinus Pharmaceuticals Inc | 113.25M |
| Adial Pharmaceuticals Inc | 5.025M |
| Poseida Therapeutics Inc | 198.65M |
| Viracta Therapeutics Inc | 39.57M |
| Biomea Fusion Inc | 144.92M |